Health & beauty
Constellate Proteomics
Constellate Proteomics
A TU Delft spin-out whose RAYmAb platform runs four antibody quality checks on a small, untreated sample in minutes.
Delft, Netherlands. Spun out of TU Delft in February 2026 by Carlos de Lannoy (CEO), Arian Khoshchin and Dennis de Beeld.
IO+ reported a 150,000 euro pre-seed round from Tech Scout Venture Fund and Imec.istart on 21 October 2026.
Written by our editors from public sources, linked in our story. Not a paid placement. Founders can request a correction.